In other countries
The same active substances on other registers, the same brand first.
- DantriumItaly · Polvere per soluzione per infusione endovenosa · Norgine Italia S.R.L.Same brand
- Dantrium, capsules 25 mgNetherlands · Capsule, hard · Norgine B.V.Same brand
- Dantrium IV, poeder voor injectievloeistof 20 mgNetherlands · Poeder voor oplossing voor injectie · BModesto B.V.Same brand
- DantriumNew Zealand · Cap 50 mgSame brand
- DantriumNew Zealand · Cap 25 mgSame brand
- Dantrium IVNew Zealand · Inj 20 mg vialSame brand
- DantriumUnited States · 20MG/VIAL · injectable · PH HealthSame brand
- DantriumUnited States · 100MG, 25MG, 50MG · capsule · PH HealthSame brand
- Agilus 120 MG Polvo Para Solucion InyectableSpain · 120 mg · polvo para solución inyectable · Norgine B.V.Same substance
- AgilusEuropean Union · Norgine B.V.Same substance
- AgilusCroatiaSame substance
- AgilusItaly · Polvere per soluzione iniettabile · Norgine BVSame substance
- Agilus 120 mg poeder voor oplossing voor injectieNetherlands · Poeder voor oplossing voor injectie · Norgine B.V.Same substance
- RevontoUnited States · 20MG/VIAL · injectable · UswmSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Dantrolene
- Strength
- 20 MG / VIAL
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 31 Dec 1993
- Registration
- DIN 01997572
- Marketing authorisation holder
- Knight Therapeutics INC.
- ATC code
- M03CA01
- Supply
- PRESCRIPTION